Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Theseus Pharmaceuticals, Inc. | President and CFO | Common Stock | 0 | $0 | $3.05 | Feb 14, 2024 | Direct |
Theseus Pharmaceuticals, Inc. | President and CFO | Restricted Stock Units | 0 | $0 | $3.05 | Feb 14, 2024 | Direct |
Theseus Pharmaceuticals, Inc. | President and CFO | Stock Option (Right to Buy) | 0 | Feb 14, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
THRX | Theseus Pharmaceuticals, Inc. | Feb 14, 2024 | 3 | $0 | 4 | Feb 14, 2024 | President and CFO |
THRX | Theseus Pharmaceuticals, Inc. | Mar 1, 2023 | 1 | $0 | 4 | Mar 2, 2023 | Chief Financial Officer |
THRX | Theseus Pharmaceuticals, Inc. | Feb 17, 2023 | 1 | $0 | 4 | Feb 21, 2023 | Chief Financial Officer |
THRX | Theseus Pharmaceuticals, Inc. | Nov 30, 2022 | 1 | $10K | 4 | Dec 1, 2022 | Chief Financial Officer |
THRX | Theseus Pharmaceuticals, Inc. | Feb 18, 2022 | 1 | $0 | 4 | Feb 23, 2022 | Chief Financial Officer |
THRX | Theseus Pharmaceuticals, Inc. | Dec 21, 2021 | 1 | $20K | 4 | Dec 22, 2021 | Chief Financial Officer |
THRX | Theseus Pharmaceuticals, Inc. | Oct 6, 2021 | 0 | $0 | 3 | Oct 6, 2021 | Chief Financial Officer |